Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • December 9th, 2020 • Rose William • Pharmaceutical preparations
Contract Type FiledDecember 9th, 2020 Company IndustryThis letter, dated as of the date set forth on the signature page hereto, is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and one or more designated representatives (the “Representatives”) of the Underwriters named therein (the “Underwriters”), relating to an underwritten public offering of Class A common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Offering”).